Volume 27, Number 1—January 2021
Synopsis
Aspergillosis Complicating Severe Coronavirus Disease
Figure 2

Figure 2. Timeline of cases, series, and cohort studies reported to describe emergence of coronavirus disease–associated pulmonary aspergillosis. Reports from China are indicated according to relative times that patients were given care; case series describing CAPA cases are depicted according to approximate time publication became available (preprint or publication), except as indicated (*). BAL, bronchioalveolar lavage; CAPA, coronavirus disease–associated pulmonary aspergillosis; ECMO, extracorporeal membrane oxygenation; EU, European Union; ICU, intensive care unit; IL-6, interleukin 6.
Page created: September 25, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.